ABSTRACT Six male subjects were exposed for two hours during light physical exercise to 2-81 mmol/m3 (293 mg/r3) of styrene on one occasion and to a mixture of 2-89 mmolm3 (301 mg/m3) of styrene and 21-3 mmollm3 (1240 mg/m3) of acetone on another (combination study). About 68% of the dose (somewhat more than 4 mmol) of styrene was taken up. The arterial blood concentration of styrene reached a relatively stable level after about 75 minutes of exposure of about 18 and 20 ,umoiIl after the single and combined exposure, respectively. Calculated values of mean blood clearance were 1-9 /min in the styrene study and 1-6 /min in the combination study; the half life of styrene in blood was about 40 minutes in both studies. The concentration of non-conjugated styrene glycol increased linearly during exposure and reached about 3 umol/l at the end of exposure and was eliminated with a half life of about 70 minutes. Styrene-7,8-oxide was detected and quantified in the blood in a complementary study. The half lives for the excretion of mandelic and phenylglyoxylic acid in the urine were about four and nine hours, respectively, in both studies.
Styrene is one of the most widely used raw materials in the modem polymer industry and the most extensive and intensive exposure occurs in the reinforced plastics industry.' Laminaters are also often exposed to acetone used as a cleaning agent. 2 Exposure of experimental animals and man to isopropanol or its keto metabolite acetone has been shown to potentiate the effects of hepatic and renal toxins such as chlorinated hydrocarbons3-9 perhaps by increasing their covalent binding to hepatic proteins.'01" Acetone is largely responsible for the remarkable potentiating ability of isopropanol,'2 which may be important when considering occupational exposure where exposure to a variety of chemical agents can alter the toxic effects of any one of them.
The mechanism of potentiation of hepatotoxicity has been postulated to be either non-specific membrane changes which render the cell more susceptible to toxic injury4 or increased bioactivation of the toxicants to reactive intermediates,4671113-'7 or both. Other effects on cellular function or metabolism, however, cannot be excluded.671' Wigaeus, Significantly reduced hepatic glutathione concentrations and slightly increased hepatic cytochrome P-450 levels have been shown in rats after inhalation exposure to acetone alone and to a mixture of acetone and styrene. 47 A dose dependent depression of hepatic glutathione level has been observed after inhalation exposure to styrene.48 The covalent binding of SO to rat liver macromolecules has been shown to be dependent on the glutathione content of the liver.36
The purpose of this study was to investigate if the uptake, distribution, metabolism, or elimination, or a combination of these, of styrene in man after an acute exposure was modified by simultaneous exposure to acetone at the recommended Swedish short term exposure limit concentrations.
Subjects and methods
The volunteers were six healthy men with an average age of 26 (range [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] , an average weight of 69 kg (range 60-80) and an average height of 177 cm (range 172-180). They had no occupational exposure to solvents and none had suffered from any disease having a detrimental effect on the function of the respiratory and circulatory systems.
The subjects were exposed in pairs in an exposure chamber for two hours to 2*81 (SD 0.03) mmo/m3 (293 mg/m3) of styrene on one occasion and to a mixture of 2*89 (SD 0.04) mmolm3 (301 mg/i3) of styrene and 21-3 (SD 0.2) mmolm3 (1240 mg/i3) of acetone on another (combination study). The two exposures were at least one month apart. The recommended Swedish short term exposure limit value is 2-88 mmol/m3 (300 mg/i3) for styrene and 20-7 mmolm3 (1200 mg/i3) for acetone. The exposures were performed during light physical exercise (work load of 50 W) on a bicycle ergometer.
The uptake of styrene was measured using the Douglas bag technique. Unchanged styrene and the styrene metabolites styrene glycol (SG) and styrene oxide (SO) were analysed by gas chromatography in arterial blood sampled during and after exposure (sampling times are shown in fig 1) . The styrene concentration in subcutaneous adipose tissue was determined by gas chromatography in biopsy specimens taken 30 and 90 minutes after exposure. The concentrations of mandelic and phenylglyoxylic acid (MA and PGA) in the urine, in samples taken up to about 25 hours after exposure, were analysed by isotachophoresis. For details of the exposure conditions and the analytical methods used in the deter-Uptake, distribution, metabolism, and elimination ofstyrene in man mination of styrene and its metabolites the reader is referred to the report by Wigaeus et al.49
Acetone in the inspiratory air was analysed using the same gas chromatographic equipment as for styrene. The analysis of acetone in blood was performed using a headspace technique similar to that described elsewhere.50 Individual calibration curves were obtained by adding 2 ,ul of standard solutions of styrene and acetone in dimethylsulphoxide (DMSO) to 1 ml of blood. A constant volume of 1 ml blood and 2 ,ul of DMSO was used throughout the experiment. The concentration of acetone in subcutaneous adipose tissue was analysed by a gas chromatographic "purge-and-trap" method.51
Student's t test for dependent observations was used for statistical analysis and a probability of 0-05 was taken as the criterion of significance.
Results
The total and relative uptakes of styrene were similar during the single and combined exposures, (SD 0-4) and 4-2 (SD 0-6) mmol, and 68 (SD 5) and 67 (SD 5) per cent (table 1). The uptake of acetone was about 20 mmol, calculated from the amount supplied and assuming a relative uptake of 45%.50
The styrene concentration in the arterial blood (five subjects only because of the failure to introduce the catheter in one subject) increased during the first 75 minutes and then approached a steady state (fig 1) . At the termination of exposure the mean concentration was 18 (SD 1) and 20 (SD 2) ,umoVl in the single and combined exposures, respectively; this difference was not statistically significant. The acetone concentration in blood The total blood clearance, Cl4, of styrene (calculated from Cl4 = dose/AUCQ)52 was 1-9 (SD 0-3) /min with the single exposure and 1-6 (SD 0-3) /min with the combined exposure (table 2). This difference was not statistically significant.
The rate of elimination of styrene from the blood after exposure is shown in figs 1 and 2 and was considered to show a biphasic decay. Individual semilogarithmic plots of blood concentration versus time were treated by the method of residuals so as to resolve the curves into a linear terminal phase of slope f3, and a linear initial phase of slope &3 (fig 2) . The half life (t1/2) for the rapid distribution phase (0-5 min, a) was 1-9 (SD 0-9) min and 1-1 (SD 0-1) min, and the t1/2 of the elimination phase (10-120 min, /) was 38-8 (SD 7-4) min and 35-0 (SD 10-2) min in the single and combined studies respectively (table 2). These differences were not statistically significant. A monoexponential decline (0-120 min) with a t1/2 of 3-1 (SD 0-5) h was observed for acetone in blood. and 90 minutes after exposure. The ratio of styrene in adipose tissue 30 minutes after exposure to that in arterial blood at the end of exposure was 3*5 (SD 0.5) in the single study and 3-9 (SD 3.7) in the combined study. The corresponding ratio for acetone was 0 35 (SD 0.08).
The arterial blood concentration of nonconjugated SG increased continuously during exposure and reached 3-1 (SD 1.2) ,umol/l in the single exposure study and 3-2 (SD 1.5) ,AmoLlI in the combined study (fig 3) . SO could not be detected in any of the samples in this experiment. After some analytical modifications'9 a complementary study with four subjects was performed and 0 05 (SD 0.03) J,moVI of SO and 2-1 (SD 0-3) ,umol/I of SG were detected in venous blood collected 5-30 minutes after exposure.
A monoexponential decline of SG in blood was observed (fig 4) . The mean t1/2 (2.5-120 min) was 71 (SD 14) minutes in the single exposure study and 66 (SD 4) minutes in the combined study (table 2), a non-significant difference.
The cumulative urinary excretion of MA and PGA within a mean of 25 (SD 2) hours after exposure represented 51 (SD 8) per cent of the total uptake in the single exposure study. The corresponding value was 52 (SD 13) per cent within 24 (SD 4) hours in the combined study. The excretion rates of MA and PGA were considered to decline monoexponentially within 20 hours of exposure, and no difference between the two exposure condi- , app) , however, implying a perfusion limited metabolic clearance. 56 The extrahepatic metabolism of styrene is not necessarily perfusion limited, however, even at low concentrations and the activities of styrene mono-oxygenase and epoxide hydratase in the extrahepatic tissues of many species are lower, and therefore easier to saturate, than those in the liver.'8-2' Consequently the stimulation of extrahepatic drug metabolising enzymes might increase the rate of clearance of styrene. The lung may be of particular importance since it receives all of the cardiac output"; changes in tissue perfusion might also modify tissue extraction and hence clearance.
The t112 of styrene in blood is dependent on Cl4
and Vd: (t1/2 = ln 2 x Vd/Ck).52 In rats Vd of styrene is independent of the dose (12-5-90.3 gmolIkg) wheras the Ck is dose dependent, giving a longer t1/2 with increasing doses.58 The calculated mean values of Vd, Clt, and t1/2 were all somewhat lower in the combined study compared with the single exposure study (table 2) .
In this study the solvent concentrations, work load, or exposure time, or a combination of these, were not adequate enough to cause a noticeable interference of Ck. The minimal blood acetone concentration capable of inducing carbon tetrachloride hepatotoxicity in rats has been estimated to be about 5 mmolIl8-that is, only about eight times higher than the blood concentration obtained in this study. Pretreatment of rats with high doses of acetone (60 mmollkg intraperitoneally) has been shown to affect the hepatic microsomal drug metabolising activity within 15 minutes.45 At lower doses (2-2 mmollkg intraperitoneally) acetone did not modify the total urinary excretion of mandelic and phenylglyoxylic acid after an equimolar dose of styrene as compared with the excretion after administration of styrene alone. 27 The possible modification of the formation of SO from styrene and the subsequent hydration to SG, however, is of greater toxicological importance.
No modification of either the formation or the oxidation, or both, of SG or the excretion of MA and PGA was seen in the combined exposure. An increased concentration of SG in blood and a delayed excretion of MA in the urine have been noted after the co-administration of ethanol (p.o) and styrene, as compared with styrene inhalation alone. 25 The present study did not show any significant interactions of acetone on the uptake, distribution, metabolism, or elimination, or a combination of these, of styrene during acute co-exposure to acetone at the recommended Swedish short term exposure limit concentrations and light physical work. 
